Transcription factor SP2 enhanced the expression of Cd14 in colitis-susceptible C3H/HeJBir

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Zschemisch, Nils Holger ^a   Brüsch, Inga ^a   Hambusch, Anne Sophie ^a   Bleich, André ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP2; PROTEIN BINDING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; BONE MARROW DERIVED MACROPHAGE; C3H/HEJBIR MOUSE; COLITIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; GEL MOBILITY SHIFT ASSAY; GENETIC POLYMORPHISM; INBRED MOUSE STRAIN; INFLAMMATORY BOWEL DISEASE; LUCIFERASE ASSAY; MOUSE; NONHUMAN; PATHOGENESIS; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION; ALLELE; ANIMAL; CELL LINE; GENETICS; METABOLISM; ULCERATIVE COLITIS;

ALLELES; ANIMALS; ANTIGENS, CD14; CELL LINE; COLITIS, ULCERATIVE; MICE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SP2 TRANSCRIPTION FACTOR;

EID: 84970021301     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0155821     Document Type: Article

References (51)

1. Frolova L, Drastich P, Rossmann P, Klimesova K, Tlaskalova-Hogenova H. Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in Biopsy samples of patients with inflammatory bowel diseases: upregulation expression of TLR2 in terminal ileum of patients with ulcerative colitis. 2008; J Histochem Cytochem. 56: 267-274. PMID: 18040078
2. Yun J, Xu CT, Pan BR Epidemiology and gene markers of ulcerative colitis in the Chinese. World J Gastroenterol. 2009; 15: 788-803. PMID: 19230040
3. Lakatos PL, Kiss LS, Palatka K, Altorjay I, Antal-Szalmas P, Palyu E, et al. Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease. 2011; Inflamm Bowel Dis. 17: 767-777. doi: 10.1002/ibd.21402 PMID: 20865702
4. de Buhr MF, Hedrich HJ, Westendorf AM, Obermeier F, Hofmann C, Zschemisch, et al. Analysis of Cd14 as a genetic modifier in experimental inflammatory bowel diseases (IBD) in mice. 2009; Inflamm Bowel Dis. 15: 1824-1836. doi: 10.1002/ibd.21030 PMID: 19637338
5. de Buhr M, Mähler M, Geffers R, Hansen W, Westendorf AM, Lauber J, et al. Cd14, Gbp1, and Pla2g2a: three major candidate genes for experimental IBD identified by combining QTL and microarray analysis. 2006; Physiol Genomics. 25: 426-434. PMID: 16705022
6. Bleich A, Büchler G, Bechwith J, Petell LM, Affourtit JP, King BL, et al. Cdcs1 a major colitis susceptibility locus in mice; subcongenic analysis reveals genetic complexity. 2010; Inflamm Bowel Dis. 16: 765-775. doi: 10.1002/ibd.21146 PMID: 19856416
7. Büchler G, Wos-Oxley ML, Smoczek A, Zschemisch NH, Neumann D, Pieper DH et al. Strain-specific colitis susceptibility in IL10-deficient mice depends on complex gut microbiota-host reactions. 2012; Inflamm Bowel Dis. 18: 943-954. doi: 10.1002/ibd.21895 PMID: 22238116
8. Simmons DL, Tan S, Tenen DG, Nicholson-Weller A, Seed B. Monocyte antigen CD14 is a phospholipids anchored membrane protein. 1989; Blood. 73: 284-289. PMID: 2462937
9. Dziarski R, Viriyakosol S, Kirkland TN, Gupta D. Soluble CD14 enhances membrane CD14-mediated responses to peptidoglycan: structural requirements differ from those for responses to lipopolysaccharide. 2000; Infect Immun. 68: 5254-5260. PMID: 10948152
10. Bufler P, Stiegler G, Schuchmann M, Hess S, Krüger C, Stelter F, et al. Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants. 1995; Eur J Immunol. 25: 604-610. PMID: 7533093
11. Haziot A, Rong GW, Bazil V, Silver J, Goyert SM Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-alpha production by cells in whole blood. J Immunol. 1994; 141: 547-552.
12. Landmann R, Fisscher AE, Olbrecht JP. (1992) Interferon-gamma and interleukin-4 down regulate soluble CD14 release in human monocytes and macrophages. 1992; J Leukoc Biol. 52: 323-330. PMID: 1381744
13. Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, Arditi M. Decreased expression of Toll-like receptor 4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. 2001; J Immunol. 167: 1609-1616. PMID: 11466383
14. Suzuki M, Hisamatsu T, Podolsky DK. Gamma interferon augments the intracellular pathways for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intercellular Toll-like receptor 4- MD-2 complex. 2003; Infect Immun. 71: 3503-3511. PMID: 12761135
15. Munthe-Kaas MC, Torjussen TM, Gervin K, Lødrup Carlsen KC, Carlsen KH, Granum B, et al. CD14 polymorphisms and serum CD14 levels through childhood: A role for gene methylation? 2010; J Allergy Clin Immunol. 125: 1361-1368. doi: 10.1016/j.jaci.2010.02.010 PMID: 20398919
16. Matsuura K, Ishida T, Setoguchi M, Higuchi Y, Akizuki S, Yamamoto S. Identification of a tissue-specific regulatory element within the murine CD14 gene. 1992; J Biol Chem. 267: 21787-21794. PMID: 1383228
17. Zhang DE, Hetherington CJ, Tan S, Dziennis SE, Gonzalez DA, Chen HM, et al. Sp1 is a critical factor for the monocytic specific expression of human CD14. 1994; J Biol Chem. 269: 11425-11434. PMID: 7512565
18. Liu S, Shapiro RA, Nie S, Zhu D, Vodovotz Y, Billiar TR. Characterization of the rat CD14 promoter and its regulation by transcription factors AP1 and Sp family proteins in hepatocytes. 2000; Gene. 250: 37-147.
19. Ibeagha-Awenu EM, Lee JW, Ibeagha AE, Zhao X. Bovine cd14 gene characterization and relationship between polymorphisms and surface expression on monocytes and polymorphonuclear neutrophils. 2008; BMC Genetics. 9: 50 doi: 10.1186/1471-2156-9-50 PMID: 18691417
20. Vychodilova-Krenkova L, Matiasovic J, Horin P. Single nucleotide polymorphisms in four functionally related immune response genes in the horse: CD14, TLR4, Cϵ and Fcϵ R1 alpha. 2005; Int J Immunogenet. 32: 277-283. PMID: 16164694
21. Liu HH, Hu Y, Zheng M, Suhoski MM, Engleman EG, Dill DL, et al. Cd14 SNPs regulate the innate immune response. 2012; Mol Immunol. 51: 112-127. doi: 10.1016/j.molimm.2012.02.112 PMID: 22445606
22. Tan CY, Chen YL, Wu LS, Liu CF, Chang WT, Wang JY. (2006) Association of Cd14 promoter polymorphisms and soluble levels in mite allergen sensitization of children in Taiwan. 2006; J Hum Genet. 1: 59-67.
23. Lange J, Heinzmann A, Zehle C, Kopp M. CT genotype of promoter polymorphism C159T in the CD14 gene associated with lower prevalence of atopic dermatitis and lower IL-13 production. 2005; Pediatr Allergy Immunol. 16: 456-457. PMID: 16101942
24. Lichy C, Meiser H, Grond-Ginsbach C, Buggle F, Dörfer C, Grau A. Lipopolysaccharide receptor CD14 polymorphism and risk of stroke in a south-german population. 2002; J Neurol. 249: 821-823. PMID: 12140663
25. Lima-Neto LG, Hirata RD, Luchessi AD, Silbiger VN, Stephano MA, Sampaio M, et al. Cd14 and IL6 polymorphisms are associated with a pro-atherogenic profile in young adults with acute myocardial infaction. J Thromb Trombolysis. 2013 Oct; 36(3): 332-40.
26. Hubacek JA, Rothe G, Pit'ha J, Skodov Z, Staněk V, Poledne R, et al. C(-260) - >T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. 1999; Circulation. 99: 3218-3220. PMID: 10385492
27. Pu H, Yin J, Zhang D, Wang Y, Zhou R, Jiang L, et al. The association between CD14 gene C-260T polymorphism and coronary heart disease risk: a meta-analysis. Mol Biol Rep. 2013 Jun; 40(6):4001-8. doi: 10.1007/s11033-012-2478-y PMID: 23277403
28. Alavi-Naini S, Salimi S, Sharifi-Mood B, Dovoodikia AA, Moody B, Naghavi A. Association between CD14 C-159T polymorphism and serum soluble CD14 with pulmonary tuberculosis. 2012; Int J Tuberc Lung Dis. 16: 1383-1387. doi: 10.5588/ijtld.11.0827 PMID: 23107636
29. Zhao MY, Xue Y, Zhao ZQ, Li FJ, Fan DP, Wei LL, et al. Association of CD14 G(-1145)A and C(-159)T polymorphisms with the reduced risk for tuberculosis in a Chinese Han population. 2012; Genet Mol Res. 11: 3425-3431. doi: 10.4238/2012.September.25.11 PMID: 23079836
30. Rajasuriar R, Kong YY, Nadarajah R, Abdullah NK, Spelman T, Yuhana MY, et al. The CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte/macrophage activation in treated HIV-infected individuals. J Transl Med. 2015 Jan 27; 13:30. doi: 10.1186/s12967-015-0391-6 PMID: 25622527
31. Mohamed JA, DuPont HL, Flores J, Palur H, Nair P, Jiang ZD, et al. Single nucleotide polymorphism in the promoter of the gene encoding the lipopolysaccharide receptor CD14 are associated with bacterial diarrhea in US and Canadian travelers to Mexico. 2011, Clin Infect Dis. 52: 1332-1341. doi: 10.1093/cid/cir228 PMID: 21596674
32. Griga T, Klein W, Epplen JT, Hebler U, Stachon A, May B. CD14 expression on monocytes and soluble CD14 plasma levels in correlation to the promoter polymorphisms of the endotoxin receptor CD14 gene in patients with inactive Crohn's disease. 2005; Hepatogastroenterology. 52: 808-811. PMID: 15966209
33. Obana N, Takahashi S, Kinouchi Y, Negoro K, Takagi S, Hiwatashi N, et al. Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene, CD14. 2002; Scand J Gastroenterol. 37: 699-704. PMID: 12126249
34. Huebner C, Petermann I, Lam WJ, Shelling AN, Ferguson LR. Characterization of single-nucleotide polymorphisms relevant to inflammatory bowel disease in commonly used gastrointestinal cell lines. 2010; Inflamm Bowel Dis. 16: 282-295. doi: 10.1002/ibd.21043 PMID: 19653290
35. Kim EJ, Chung WC, Lee KM, Paik CN, Jung SH, Lee BI, et al. Association between toll-like receptors/CD14 gene polymorphisms and inflammatory bowel disease in Korean population. 2012 1; J Korean Med Sci. 27: 72-77. doi: 10.3346/jkms.2012.27.1.72 PMID: 22219617
36. Wang Z, Hu J, Zhou J, Zhong J. Association between CD14 gene C-260T polymorphism and inflammatory bowel diseases: a meta-analysis. PlosOne. 2012; 7(9):e45144. doi: 10.1371/journal.pone.0045144
37. Baumgart DC, Büning C, Geerdts L, Schmidt HH, Genschel J, Fiedler T, et al. The c.1-260C>T promoter variant of CD14 but not the c.-896>G (p.D299G) variant of the toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease. 2007; Digestion. 76: 196-202. doi: 10.1159/000112646 PMID: 18174680
38. Weischenfeldt J, Porse B. Bone marrow-derived macrophages (BMM): Isolation and Application. 2008; CSH Protoc. 2008 Dec 1; 2008:pdb.prot5080. doi: 10.1101/pdb.prot5080
39. Baur F, Nau K, Sadic D, Allweis L, Elsässer HP, Gillemans N, et al. Specificity Protein 2 (Sp2) is essential for mouse development and autonomous proliferation of mouse embryonic fibroblasts. PLoS One. 2010 Mar 8; 5(3):e9587. doi: 10.1371/journal.pone.0009587 PMID: 20221402
40. Waechter V, Schmid M, Herova M, Weber A, Günther V, Marti-Jaun J. Characterization of the promoter and the transcriptional regulation of the lipoxin A4 receptor (FPR2/ALX) gene in human monocytes and macrophages. 2012; J Immunol. 188: 1856-1867. doi: 10.4049/jimmunol.1101788 PMID: 22246625
41. van Heel DA, Udalova IA, De Silva AP, McGovern DP, Kinouchi Y, Hull J, et al. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF (-kappa)B transcription factors. 2002; Hum Mol Genet. 11:1281-1289. PMID: 12019209
42. Staitieh BS, Fan X, Neveu W, Guidot DM. Nrf2 regulates PU.1 expression and activity in the alveolar macrophage. 2015; Am J Physiol Lung Cell Mol Physiol. 308: L1086-L1093. doi: 10.1152/ajplung.00355.2014 PMID: 25840997
43. Lau WL, Liu SH, Pahlevan S, Yuan J, Khazeali M, Ni Z, et al. Role of Nrf2 dysfunction in uremia-associated intertinal inflammation and epithelial barrier disruption. 2015; Dig Dis Sci. 60: 1215-1222. doi: 10.1007/s10620-014-3428-4 PMID: 25399330
44. Khor TO, Huang MT, Kwon H, Chan JY, Reddy BS, Kong AN. Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium - induced colitis. 2006; Cancer Res. 66: 11580-11584. PMID: 17178849
45. Crissey MAS, Guo RJ, Fogt F, Li H, Katz JP, Silberg DG, et al. The homeodomain transcription factor Cdx1 does not behave as an oncogene in mouse intestine. 2008; Neoplasia. 10: 8-19. PMID: 18231635
46. Calon A, Gross I, Lhermitte B, Martin E, Beck F, Duclos B, et al. Different effects of Cdx1 and Cdx2 homeobox genes in a murine model of intestinal inflammation. 2007; Gut. 56: 1688-1695. PMID: 17595234
47. Rahimi AA, Gee K, Mishra S, Lim W, Kumar A. STAT-1 mediates the stimulatory effect of IL-10 on CD14 expression in human monocytic cells. 2005; J Immunol. 174: 7823-7832. PMID: 15944287
48. Moorefield KS, Fry SJ, Horowitz JM. Sp2 DNA binding activity and trans-activation are negatively regulated in mammalian cells. 2004; J Biol Chem. 279: 13911-13924. PMID: 14726517
49. LeVan TD, Bloom JW, Bailey TJ, Karp CL, Halonen M, Martinez FD, A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. 2001; J Immunol. 167: 5838-5844. PMID: 11698458
50. Völkel S, Stielow B, Finkernagel F, Stiewe T, Nist A, Suske G. Zinc finger independent genome-wide binding of Sp2 potentiates recruitment of histone-Fold protein nf-y distinguishing It from Sp1 and Sp3. PLoS Genet. 2015 Mar 20; 11(3):e1005102. doi: 10.1371/journal.pgen.1005102 PMID: 25793500
51. Terrados G, Finkernagel F, Stielow B, Sadic D, Neubert J, Herdt O, et al. Genome-wide localization and expression profiling establish Sp2 as a sequence-specific transcription factor regulating vitally important genes. 2012; Nucleic Acids Res. 40: 7844-7857. doi: 10.1093/nar/gks544 PMID: 22684502